Sugi Predict

Sugi Predict / Targets / NUCB2

NUCB2

Nucleobindin-2 · P80303 · NUCB2 on Sugi Atlas →

0 patent compounds predicted against NUCB2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NUCB2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy of BNG-1 to Treat Acute Ischemic Stroke PHASE3COMPLETED
18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System PHASE2WITHDRAWN
Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5 PHASE2NOT_YET_RECRUITING
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings nanUNKNOWN
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 nanUNKNOWN
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN) nanRECRUITING
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome nanCOMPLETED
Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum nanCOMPLETED
Testing of NBIA Genes: Analysis of Genetic Heterogeneity and Validation of Mitochondrial Markers for Assessing Causality of Sequence Variants. nanCOMPLETED
RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide nanENROLLING_BY_INVITATION
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Diagnosis of Sport-related Concussion Using Urine Metabolites nanCOMPLETED
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method） nanCOMPLETED
The Southern-Norway Post-Stroke Atrial Fibrillation Study nanRECRUITING
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy nanCOMPLETED
Novel Biomarkers in Inflammatory Bowel Disease nanCOMPLETED
Biomarker Guided Discharge of Heart Failure Patients nanRECRUITING
BATokines as Biomarkers of Brown Fat in Humans nanACTIVE_NOT_RECRUITING
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm nanUNKNOWN
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging nanUNKNOWN
Identification of Biomarker Profiles GEP-NEN Patients nanUNKNOWN
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Nephron Sparing Renal Surgery and Total Nephrectomy nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Establishing Radiolabelled PSMA as a Target for Glioma Treatment nanNOT_YET_RECRUITING
Blood Sample Donations to Study the Role of Genes in Pain nanCOMPLETED
Biomarker in Tissue Samples From Patients With Ewing Sarcoma nanCOMPLETED
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a NUCB2 binder may also engage these)

ProteinNameSimilarity
P81117 — 1.000 P81117 →
Q9JI85 — 0.997 Q9JI85 →
G5EF60 — 0.985 G5EF60 →
Q02819 — 0.984 Q02819 →
Q66JA6 — 0.983 Q66JA6 →
Q06BR2 — 0.983 Q06BR2 →
Q63083 — 0.983 Q63083 →
Q7JXF7 — 0.983 Q7JXF7 →
Q6BNQ8 — 0.983 Q6BNQ8 →
Q5ZKE5 — 0.983 Q5ZKE5 →
P25582 — 0.982 P25582 →
O74903 — 0.981 O74903 →
Q6DEV3 — 0.981 Q6DEV3 →
Q61112 — 0.980 Q61112 →
A2WKK5 — 0.980 A2WKK5 →
Q9FG01 — 0.980 Q9FG01 →
Q9VTE6 — 0.980 Q9VTE6 →
O14164 — 0.980 O14164 →
Q5BKL9 — 0.980 Q5BKL9 →
O74977 — 0.980 O74977 →
Q91ZS3 — 0.980 Q91ZS3 →
Q7ZUC2 — 0.979 Q7ZUC2 →
A5YVD9 — 0.979 A5YVD9 →
B4PR07 — 0.979 B4PR07 →
Q0P569 — 0.979 Q0P569 →
Q0IE95 — 0.979 Q0IE95 →
Q9R1T4 — 0.979 Q9R1T4 →
P39931 — 0.978 P39931 →
A8XA40 — 0.978 A8XA40 →
Q9XZ63 — 0.978 Q9XZ63 →